GE HealthCare Technologies PDx — Goodwill decreased by 0.1% to $2.74B in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 0.3%, from $2.75B to $2.74B. Over 2 years (FY 2023 to FY 2025), PDx — Goodwill shows relatively stable performance with a 4.3% CAGR.
A significant increase suggests recent M&A activity, while a decrease may signal impairment charges due to underperforming acquisitions.
Represents the premium paid over the fair value of net assets during acquisitions attributed to the Pharmaceutical Diagn...
Standard balance sheet item for segments that have grown through acquisition, common in the medical device industry.
gehc_segment_pdx_goodwill| Q4 '21 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $2.53B | $2.53B | $2.53B | $2.53B | $2.53B | $2.53B | $2.53B | $2.53B | $2.53B | $2.53B | $2.75B | $2.75B | $2.77B | $2.75B | $2.74B |
| QoQ Change | — | -0.0% | +0.0% | +0.0% | -0.0% | +0.0% | +0.0% | -0.0% | +0.0% | -0.0% | +8.6% | +0.0% | +0.9% | -1.0% | -0.1% |
| YoY Change | — | -0.0% | — | — | — | +0.0% | +0.0% | -0.0% | +0.0% | -0.0% | +8.5% | +8.6% | +9.5% | +8.4% | -0.3% |